Clinical utility of Neutrophil-Lymphocyte Ratio for the prediction of multivessel disease in patients with STEMI: A cross-sectional, retrospective study

Authors

DOI:

https://doi.org/10.61708/c9k8ze18

Keywords:

ST Elevated Myocardial Infarction, Coronary Artery Disease, Neutrophil, Lymphocyte count, Prognosis

Abstract

Introduction: Studies have shown that an elevated neutrophil-lymphocyte ratio (NLR) is associated with cardiovascular events. Given the limited local availability of diagnostic-therapeutic resources to offer immediate adequate management of patients with coronary syndrome, NLR could be a low-cost predictor marker to identify patients with multiple coronary vessel involvement. Objective: To demonstrate the diagnostic utility of NLR for identifying multivessel disease (MVD) in patients with STEMI. Materials and methods: A retrospective cross-sectional study was conducted in patients with STEMI who underwent reperfusion therapy between 2020 and 2023. The association of serum inflammation parameters (neutrophils, lymphocytes, NLR, and US troponin T) with the presence of MVD determined by coronary angiography was assessed. Independent factors associated with MVD were also studied. ROC curves were performed to assess sensitivity and specificity and optimal cut-off points to predict the presence of MVD. Results: A slight increase in NLR was observed in people with MVD, although it was not statistically significant (p = 0.648). A NLR value of 2.075 was determined as a cut-off to predict MVD (sensitivity 94.1%, specificity 90%, AUC = 0.568). Multiple regression analysis did not determine independent factors associated with MVD. Conclusions: NLR was not related to a higher incidence of MVE in patients with STEMI. Therefore, inflammatory markers were not useful to predict the presence of MVD in patients admitted for STEMI.

Downloads

Download data is not yet available.

References

OMS. Organización Mundial de la Salud. 2021 [cited 2024 Aug 7]. Enfermedades cardiovasculares. Available from: https://www.who.int/es/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

AHA/ASA. www.heart.org. 2024 [cited 2024 Aug 7]. Inflammation and Heart Disease. Available from: https://www.heart.org/en/health-topics/consumer-healthcare/what-is-cardiovascular-disease/inflammation-and-heart-disease

Espinosa-Yépez KR, García-Cevallos MP. Infarto agudo de miocardio en Ecuador: carga de la enfermedad y distribución geográfica. Metro Cienc. 2023 Sep 29;31(3):18-27. https://doi.org/10.47464/MetroCiencia/vol31/3/2023/18-27 DOI: https://doi.org/10.47464/MetroCiencia/vol31/3/2023/18-27

Severino P, D'Amato A, Pucci M, Infusino F, Adamo F, Birtolo LI, et al. Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction. Int J Mol Sci. 2020 Oct 30;21(21):8118. https://doi.org/10.3390/ijms21218118 DOI: https://doi.org/10.3390/ijms21218118

Venkatraghavan L, Tan TP, Mehta J, Arekapudi A, Govindarajulu A, Siu E. Neutrophil Lymphocyte Ratio as a predictor of systemic inflammation - A cross-sectional study in a pre-admission setting. F1000Research. 2015 May 22;4:123. https://doi.org/10.12688/f1000research.6474.1 DOI: https://doi.org/10.12688/f1000research.6474.1

Angkananard T, Anothaisintawee T, McEvoy M, Attia J, Thakkinstian A. Neutrophil Lymphocyte Ratio and Cardiovascular Disease Risk: A Systematic Review and Meta-Analysis. BioMed Res Int. 2018 Nov 11;2018:1-11. https://doi.org/10.1155/2018/2703518 DOI: https://doi.org/10.1155/2018/2703518

Bustamante U. MA, Tello M, Carvache-Franco M, Carvache-Franco O, Carvache-Franco W. Statistical determination of service quality gaps in primary health care in Guayas, Ecuador. Machado A, editor. PLOS ONE. 2024 Mar 15;19(3):e0299994. https://doi.org/10.1371/journal.pone.0299994 DOI: https://doi.org/10.1371/journal.pone.0299994

Sharma DJ, Nath HJ, Batta A, Goala AK. Neutrophil-to-Lymphocyte Ratio (NLR) Useful as a Cost-Effective Preliminary Prognostic Marker in ST-Elevation Myocardial Infarction (STEMI): An Observational Study From a Tertiary Care Hospital in Northeast India. Cureus [Internet]. 2023 Mar 29 [cited 2024 Aug 7]; Available from: https://www.cureus.com/articles/146681-neutrophil-to-lymphocyte-ratio-nlr-useful-as-a-cost-effective-preliminary-prognostic-marker-in-st-elevation-myocardial-infarction-stemi-an-observational-study-from-a-tertiary-care-hospital-in-northeast-india https://doi.org/10.7759/cureus.36885 DOI: https://doi.org/10.7759/cureus.36885

Bharmal M, Kern MJ, Kumar G, Seto AH. Physiologic Lesion Assessment to Optimize Multivessel Disease. Curr Cardiol Rep. 2022 May;24(5):541-50. https://doi.org/10.1007/s11886-022-01675-8 DOI: https://doi.org/10.1007/s11886-022-01675-8

Madjid M, Fatemi O. Components of the Complete Blood Count as Risk Predictors for Coronary Heart Disease. Tex Heart Inst J. 2013;40(1):17-29.

Wang S, Liu Q, Guo F, Zhou X, Shi J, Xie Q. Clinical utility of serum cystatin C for prediction of multi-vessel disease by coronary angiography in type 2 diabetes mellitus patients with normal renal function. BMC Cardiovasc Disord. 2020 Dec;20(1):183. https://doi.org/10.1186/s12872-020-01475-4 DOI: https://doi.org/10.1186/s12872-020-01475-4

Demi̇R M. The leuko-glycemic index can predict multivessel disease in the elderly acute myocardial infarction population? a retrospective cohort study. J Health Sci Med. 2023 Sep 28;6(5):1119-24. https://doi.org/10.32322/jhsm.1349575 DOI: https://doi.org/10.32322/jhsm.1349575

Steinacher E, Koller L, Hammer A, Baumer U, Hofer F, Kazem N, et al. Routinely available inflammation biomarkers as predictors of adverse outcomes following coronary angiography. Eur Heart J. 2023 Nov 9;44(Supplement_2):ehad655.2162. https://doi.org/10.1093/eurheartj/ehad655.2162 DOI: https://doi.org/10.1093/eurheartj/ehad655.2162

Verdoia M, Barbieri L, Di Giovine G, Marino P, Suryapranata H, De Luca G. Neutrophil to Lymphocyte Ratio and the Extent of Coronary Artery Disease: Results From a Large Cohort Study. Angiology. 2016 Jan;67(1):75-82. https://doi.org/10.1177/0003319715577529 DOI: https://doi.org/10.1177/0003319715577529

Accardi G, Caruso C. Immune-inflammatory responses in the elderly: an update. Immun Ageing. 2018 Dec;15(1):11, s12979-018-0117-8. https://doi.org/10.1186/s12979-018-0117-8 DOI: https://doi.org/10.1186/s12979-018-0117-8

Burgess S, Juergens CP, Yang W, Shugman IM, Idris H, Nguyen T, et al. Cardiac mortality, diabetes mellitus, and multivessel disease in ST elevation myocardial infarction. Int J Cardiol. 2021 Jan;323:13-8. https://doi.org/10.1016/j.ijcard.2020.08.021 DOI: https://doi.org/10.1016/j.ijcard.2020.08.021

Lima Dos Santos CC, Matharoo AS, Pinzón Cueva E, Amin U, Perez Ramos AA, Mann NK, et al. The Influence of Sex, Age, and Race on Coronary Artery Disease: A Narrative Review. Cureus [Internet]. 2023 Oct 27 [cited 2024 Jul 10]; Available from: https://www.cureus.com/articles/188543-the-influence-of-sex-age-and-race-on-coronary-artery-disease-a-narrative-review https://doi.org/10.7759/cureus.47799 DOI: https://doi.org/10.7759/cureus.47799

Rodriguez-Araujo G, Nakagami H. Pathophysiology of cardiovascular disease in diabetes mellitus. Cardiovasc Endocrinol Metab. 2018 Mar;7(1):4-9. https://doi.org/10.1097/XCE.0000000000000141 DOI: https://doi.org/10.1097/XCE.0000000000000141

Downloads

Published

2024-12-30

Issue

Section

Original article

How to Cite

1.
Chang Moran CA, Banchon Macias GA, Varas Mera GA, Vásquez Cedeño D. Clinical utility of Neutrophil-Lymphocyte Ratio for the prediction of multivessel disease in patients with STEMI: A cross-sectional, retrospective study. Gac Med JBG [Internet]. 2024 Dec. 30 [cited 2026 Mar. 7];2(3):19-25. Available from: https://gacetamedicajbgmedec.biteca.online/index.php/GMJBG/article/view/40
Crossref Cited-by logo